SSc & Puffy Fingers: Early Raynaud’s Sign?
- In patients with systemic sclerosis (SSc), Raynaud's phenomenon is often considered the initial symptom.
- A recent study in Arthritis & Rheumatology,led by Dr. Iqtidar Hanif at UTHealth Houston, examined two large U.S.
- The study included 1,377 patients diagnosed with SSc within five years of their first non-Raynaud symptom. Researchers collected data on demographics, clinical features like skin involvement and joint...
New research reshapes our understanding of systemic sclerosis (SSc),revealing that puffy fingers,frequently enough a symptom of underlying issues,may precede Raynaud’s phenomenon in some patients. this contradicts the traditional view, emphasizing the importance of recognizing choice early warning signs. A recent study across 1,377 patients highlights that non-Raynaud symptoms, notably puffy fingers and hands, can be the initial manifestation of SSc. The findings are crucial, especially for Black patients who are more likely to present with these alternative symptoms. News Directory 3 recognizes the need to stay ahead of emerging health insights. These insights could transform early detection and treatment approaches. Discover what’s next in early SSc diagnosis and management.
Puffy Fingers May Precede Raynaud’s in Systemic Sclerosis
In patients with systemic sclerosis (SSc), Raynaud’s phenomenon is often considered the initial symptom. Though, research indicates that a meaningful percentage present with other manifestations first.
A recent study in Arthritis & Rheumatology,led by Dr. Iqtidar Hanif at UTHealth Houston, examined two large U.S. cohorts. The findings revealed that 31% to 44% of SSc patients initially experienced non-Raynaud symptoms, most commonly puffy fingers or hands.
The study included 1,377 patients diagnosed with SSc within five years of their first non-Raynaud symptom. Researchers collected data on demographics, clinical features like skin involvement and joint contractures, and the presence of specific autoantibodies.
Black patients were found to be more likely to present with non-raynaud symptoms as their first sign of SSc, compared to other racial and ethnic groups.These patients also had a higher prevalence of diffuse cutaneous involvement, joint contractures, and tendon friction rubs.
The research also highlighted a higher prevalence of RNA polymerase III antibody in patients who initially presented with non-Raynaud phenomenon.
“Future research aimed at understanding and/or treating patients in the early stages of SSc should be inclusive of those presenting without [Raynaud phenomenon] if other risk features (eg, puffy fingers/hands, abnormal nailfold capillaries, skin tightening, tendon friction rubs, positivity for ANA and SSc-associated specific autoantibodies) are present,” the authors wrote.
What’s next
The study authors suggest that future research should consider including patients presenting without Raynaud’s phenomenon but with other risk factors to better understand and treat early-stage SSc.